{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20200706",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20130329",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20120119",
          "submission_class_code": "N/A",
          "submission_class_code_description": "Not Applicable"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20200706",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20150516",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20120731",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        }
      ],
      "application_number": "ANDA091634",
      "sponsor_name": "GLENMARK PHARMS LTD",
      "openfda": {
        "application_number": [
          "ANDA091634"
        ],
        "brand_name": [
          "ALYACEN 1/35"
        ],
        "generic_name": [
          "NORETHINDRONE AND ETHINYL ESTRADIOL"
        ],
        "manufacturer_name": [
          "Glenmark Pharmaceuticals Inc., USA"
        ],
        "product_ndc": [
          "68462-394",
          "68462-556"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "rxcui": [
          "310463",
          "312033",
          "392662",
          "748797",
          "749852",
          "749858",
          "1242786",
          "1242787"
        ],
        "spl_id": [
          "9d4967e6-42df-4468-99a6-9b57499497d9"
        ],
        "spl_set_id": [
          "5c02b4d3-1e2f-439a-ae45-02304ee190d1"
        ],
        "package_ndc": [
          "68462-556-84",
          "68462-556-29",
          "68462-394-84",
          "68462-394-29"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "ALYACEN 1/35",
          "active_ingredients": [
            {
              "name": "ETHINYL ESTRADIOL",
              "strength": "0.035MG"
            },
            {
              "name": "NORETHINDRONE",
              "strength": "1MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET",
          "route": "ORAL-28",
          "marketing_status": "Prescription",
          "te_code": "AB"
        }
      ]
    }
  ]
}